LYMRIT 37-01

Clinical Trial Grant

Duke Scholars

Principal Investigator Matthew Stuart McKinney Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Nordic Nanovector ASA

Start Date

September 25, 2019

End Date

September 14, 2024

Administered By

Duke Cancer Institute

Awarded By

Nordic Nanovector ASA

Start Date

September 25, 2019

End Date

September 14, 2024